Logo image of NAKA

KINDLY MD INC (NAKA) Stock Fundamental Analysis

USA - NASDAQ:NAKA - US49457M1062 - Common Stock

1.075 USD
-0.09 (-8.12%)
Last: 9/30/2025, 1:47:09 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NAKA. NAKA was compared to 101 industry peers in the Health Care Providers & Services industry. While NAKA has a great health rating, there are worries on its profitability. NAKA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year NAKA has reported negative net income.
NAKA had a negative operating cash flow in the past year.
NAKA Yearly Net Income VS EBIT VS OCF VS FCFNAKA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -1M -2M -3M

1.2 Ratios

NAKA's Return On Assets of -55.28% is on the low side compared to the rest of the industry. NAKA is outperformed by 92.08% of its industry peers.
NAKA's Return On Equity of -60.97% is on the low side compared to the rest of the industry. NAKA is outperformed by 73.27% of its industry peers.
Industry RankSector Rank
ROA -55.28%
ROE -60.97%
ROIC N/A
ROA(3y)-171.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NAKA Yearly ROA, ROE, ROICNAKA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

NAKA has a Gross Margin of 98.73%. This is amongst the best in the industry. NAKA outperforms 100.00% of its industry peers.
NAKA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for NAKA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 98.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.15%
GM growth 5YN/A
NAKA Yearly Profit, Operating, Gross MarginsNAKA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100

8

2. Health

2.1 Basic Checks

NAKA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NAKA has more shares outstanding
The debt/assets ratio for NAKA has been reduced compared to a year ago.
NAKA Yearly Shares OutstandingNAKA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M
NAKA Yearly Total Debt VS Total AssetsNAKA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

An Altman-Z score of 283.48 indicates that NAKA is not in any danger for bankruptcy at the moment.
NAKA has a Altman-Z score of 283.48. This is amongst the best in the industry. NAKA outperforms 100.00% of its industry peers.
There is no outstanding debt for NAKA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 283.48
ROIC/WACCN/A
WACC8.84%
NAKA Yearly LT Debt VS Equity VS FCFNAKA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M

2.3 Liquidity

A Current Ratio of 12.99 indicates that NAKA has no problem at all paying its short term obligations.
With an excellent Current ratio value of 12.99, NAKA belongs to the best of the industry, outperforming 98.02% of the companies in the same industry.
NAKA has a Quick Ratio of 12.99. This indicates that NAKA is financially healthy and has no problem in meeting its short term obligations.
NAKA has a Quick ratio of 12.99. This is amongst the best in the industry. NAKA outperforms 98.02% of its industry peers.
Industry RankSector Rank
Current Ratio 12.99
Quick Ratio 12.99
NAKA Yearly Current Assets VS Current LiabilitesNAKA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2

3. Growth

3.1 Past

The earnings per share for NAKA have decreased strongly by -85.77% in the last year.
NAKA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -27.67%.
NAKA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.79% yearly.
EPS 1Y (TTM)-85.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-34.4%
Revenue 1Y (TTM)-27.67%
Revenue growth 3Y2.79%
Revenue growth 5YN/A
Sales Q2Q%-36.08%

3.2 Future

The Earnings Per Share is expected to grow by 25.35% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y90.88%
EPS Next 2Y41.42%
EPS Next 3Y25.35%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAKA Yearly Revenue VS EstimatesNAKA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 1M 2M 3M
NAKA Yearly EPS VS EstimatesNAKA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2027 -0.02 -0.04 -0.06

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NAKA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NAKA Price Earnings VS Forward Price EarningsNAKA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NAKA Per share dataNAKA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

NAKA's earnings are expected to grow with 25.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y25.35%

0

5. Dividend

5.1 Amount

No dividends for NAKA!.
Industry RankSector Rank
Dividend Yield N/A

KINDLY MD INC

NASDAQ:NAKA (9/30/2025, 1:47:09 PM)

1.075

-0.09 (-8.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)11-10 2025-11-10
Inst Owners0.23%
Inst Owner ChangeN/A
Ins Owners5.05%
Ins Owner Change78.5%
Market Cap404.36M
AnalystsN/A
Price TargetN/A
Short Float %3.61%
Short Ratio1.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 180.52
P/FCF N/A
P/OCF N/A
P/B 45.09
P/tB 66.33
EV/EBITDA N/A
EPS(TTM)-0.86
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.01
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -55.28%
ROE -60.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 98.73%
FCFM N/A
ROA(3y)-171.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.15%
GM growth 5YN/A
F-Score4
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2456.96%
Cap/Sales 129.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.99
Quick Ratio 12.99
Altman-Z 283.48
F-Score4
WACC8.84%
ROIC/WACCN/A
Cap/Depr(3y)300.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.84%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-34.4%
EPS Next Y90.88%
EPS Next 2Y41.42%
EPS Next 3Y25.35%
EPS Next 5YN/A
Revenue 1Y (TTM)-27.67%
Revenue growth 3Y2.79%
Revenue growth 5YN/A
Sales Q2Q%-36.08%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-164.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-239.94%
EBIT Next 3Y201.56%
EBIT Next 5YN/A
FCF growth 1Y-649.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-583.85%
OCF growth 3YN/A
OCF growth 5YN/A